Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age

Journal of Clinical Immunology

Volumn 35, Issue 6, 2015, Pages 558-565

  Patel, Niraj C ^a   Gallagher, Joel L ^a,k   Ochs, Hans D ^b   Prescott Atkinson, Thomas ^c   Wahlstrom, Justin ^d   Dorsey, Morna ^d,e   Bonilla, Francisco A ^f   Heimall, Jennifer ^g   Kobrynski, Lisa ^h   Morris, David ⁱ   Haddad, Elie ^j  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WebbWrites   (United States)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

Children; Efficacy; Immunodeficiency; Immunoglobulin; Safety; Subcutaneous

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

AGAMMAGLOBULINEMIA; ARTICLE; ATAXIA TELANGIECTASIA; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL PNEUMONIA; BRAIN ABSCESS; BRONCHIOLITIS; BRONCHITIS; CELLULITIS; CHILD; CHROMOSOME DELETION 22Q11; COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EAR INFECTION; FEMALE; FEVER; GASTROENTERITIS; GENE THERAPY; HOME CARE; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOTHERAPY; INCIDENCE; INFANT; LENGTH OF STAY; LIVER ABSCESS; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERTON DISEASE; OSTEOMYELITIS; OTITIS; OTITIS MEDIA; PATIENT HISTORY OF THERAPY; PEDIATRICS; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PHYSICIAN ATTITUDE; PRESCHOOL CHILD; PRIMARY ANTIBODY DEFICIENCY; PRIMARY IMMUNODEFICIENCY DISEASE; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; SEVERE COMBINED IMMUNODEFICIENCY; SEX DIFFERENCE; SINUSITIS; SUBSTITUTION THERAPY; T LYMPHOCYTE DEFICIENCY; TRACHEITIS; TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VIRUS PNEUMONIA; WEIGHT GAIN; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA; ADULT; DRUG EFFECTS; EVALUATION STUDY; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INJECTIONS, SUBCUTANEOUS; MALE; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 84942197063     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-015-0190-0     Document Type: Article

References (32)

1. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med. 2000;343:1313–24.
2. Chapel H, Geha R, Rosen F. Primary immunodeficiency diseases: an update. Clin Exp Immunol. 2003;132:9–15.
3. Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases: a molecular and genetic approach. 3rd ed. New York: Oxford University Press Inc, USA; 2014.
4. Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.
5. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.
6. Quartier P, Debre M, De Blic J, de Sauvarzac R, Sayegh N, Jabado N, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr. 1999;134:589–96.
7. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109:1001–4.
8. Church JA, Borte M, Taki H, Nelson RP, Sleasman JW, Knutsen AP, et al. Efficacy and safety of privigen in children and adolescents with primary immunodeficiency. Pediatr Asthma Allergy Immunol. 2009;22:53–62.
9. Eijkhout HW, van der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med. 2001;135:165–74.
10. Stein MR, Nelson RP, Church JA, Wasserman RL, Borte M, Vermyle C, et al. Safety and efficacy of Privigen®, a novel 10 % liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies. J Clin Immunol. 2009;29:137–44.
11. Abrahamsen TG, Sandersen H, Bustness A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics. 1996;98:1127–31.
12. Berger M Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin N Am. 2008;28:413–37.
13. Gardulf A, Nicolay U, Asensio O, Bernatowska E, Bock A, Carvalho BC, et al. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies – a prospective, multi-national study. J Clin Immunol. 2006;26:177–85.
14. Ochs HD. Gupta S, kiessling, Nicolay U, Berger M. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol. 2006;26:265–73.
15. Berger M Subcutaneous administration of IgG. Immunol Allergy Clin N Am. 2008;28:413–37.
16. Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, et al. Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy. Clin Immunol. 2011;141:102–14.
17. Borte M, Pac M, Serban M, Gonzalez-Quevedo T, Grimbacher B, Jolles S, et al. Efficacy and safety of 20 % SCIg, a new 20 % immunoglobulin preparation for subcutaneous administration, in pediatric patients with primary immunodeficiency. J Clin Immunol. 2011;31:752–61.
18. Berger M, Jolles S, Orange JS, Sleasman JW. Bioavailability of IgG administered by the subcutaneous route. J Clin Immunol. 2013;33:984–90.
19. Hagan JB, Fasano MB, Spector S, Wasserman RL, Melamed I, Rojavin MA, et al. Efficacy and safety of a new 20 % immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency. J Clin Immunol. 2010;30:734–45.
20. Wasserman RL, Melamed I, Nelson RP, Knutsen AP, Fasano MB, Stein MR, et al. Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency. Clin Pharmacokinet. 2011;50:405–14.
21. Kanegane H, Imai K, Yamada M, Takada H, Ariga T, Bexon M, et al. Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases. J Clin Immunol. 2014;34:204–11.
22. Gallagher JL, Patel NC. Subcutaneous immunoglobulin replacement therapy with Hizentra® is safe and effective in two infants. J Clin Immunol. 2012;32(3):474–6.
23. Shapiro R Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics. Pediatr Allergy Immunol. 2013;24:49–53.
24. Checkley W, Epstein LD, Gilman RH, Black RE, Cabrera L, Sterling CR. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol. 1998;148:497–506.
25. Kabir I. Malek Ma, mazumder RN, Rahman MM, mahalanabis D. Rapid catch-up growth of children fed a high-protein diet during convalescence from shigellosis. Am J Clin Nutr. 1993;57:441–5.
26. Goodgame RW, Kimball K, Ou CN, White AC, Genta RM, Lifschitz CH, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology. 1995;108(4):1075–82.
27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.
28. FDA Guidance for Industry, Safety, efficacy, and pharmacokinetic studies to support marketing of immune globulin intravenous (human) as replacement therapy for primary humoral immunodeficiency. 2008. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm078526.pdf
29. Thomas MJ, Brennan VM, Chapel HH. Rapid subcutaneous immunoglobulin infusions in children. Lancet. 1993;342:1432–3.
30. Richard SA, Black RE, Checkley W. Revisiting the relationship of weight and height in early childhood. Adv Nutr. 2012;3:250–4.
31. Golden MH. Is complete catch-up possible for stunted malnourished Children? Eur J Clin Nutr. 1994;48:S58–70.
32. Ashworth A Growth rates in children recovering from protein-calorie malnutrition. Br J Nutr. 1969;23:835–45.